BUZZ-Eli Lilly, US-listed Novo Nordisk fall; Trump says weight-loss drug prices would be lowered

Reuters
10/17
BUZZ-Eli Lilly, US-listed <a href="https://laohu8.com/S/NVO">Novo Nordisk</a> fall; Trump says weight-loss drug prices would be lowered

** Shares of weight-loss drug developers Eli Lilly LLY.N and U.S.-listed shares of Novo Nordisk NOVOb.CO fall between 1% and 3% in extended trading

** Lilly down 1.3% at $811.50, Novo falls 3.6% to $54.10

** U.S. President Donald Trump says that prices of weight-loss drugs, such as Novo's Ozempic, would be lowered

** "They'll be much lower," Trump told reporters during an event in the Oval Office

** Up to last close, LLY up 6.1% and U.S.-listed Novo down 34.8% YTD

(Reporting by Sneha S K)

((Sneha.SK@thomsonreuters.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10